The Daily

This week, The Daily is revisiting some of our favorite episodes of the year and checking in on what has happened in the time since they first ran.This episode contains strong language.Bartenders, sous chefs, wait staff — back in August, managers in the U.S. hospitality industry were struggling to fill a range of roles at their establishments.One owner of a gourmet burger restaurant in Houston said that before the pandemic, a job opening could easily get 100 applicants — but that was no longer the case; applications were in the single digits. “I had never seen it like this before in my career,” he told us. “I’ve been doing this for over 25 years.”Managers blamed pandemic unemployment benefits for the dearth of job seekers. Employees said that the pandemic had opened their eyes to the realities of work.Today, we return to the country’s labor shortage to find out why so many Americans have left their jobs, and whether the people we spoke to back in August are working again.Sign up here to get The Daily in your

A year that started with the mass introduction of Covid vaccines and the astonishing scenes of rioting at the Capitol is ending with concern about new virus variants and fears about the effects of a warming climate.As we approach the end of the year, we listen back to more of the events that defined 2021.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: In a volatile year again dominated by politics and the pandemic, “The Daily” sought out personal stories. Here’s a look back on the episodes that our team can’t forget.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

A year that started with the mass introduction of Covid vaccines and the astonishing scenes of rioting at the Capitol is ending with concern about new virus variants and fears about the effects of a warming climate.As we approach the end of the year, we listen back to more of the events that defined 2021.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: In a volatile year again dominated by politics and the pandemic, “The Daily” sought out personal stories. Here’s a look back on the episodes that our team can’t forget.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

By the end of last year, if you needed a coronavirus test, you could get one. But when vaccines arrived, focus shifted.Many of the vaccinated felt like they didn’t need tests and demand took a nosedive. Testing sites were closed or converted into vaccination sites. And Abbott Laboratories, a major test manufacturer, wound up destroying millions.However, with the surge of the new Omicron variant, which is less susceptible to vaccines, demand for testing is back — and it is outstripping supply.Guest: Sheryl Gay Stolberg, a Washington correspondent, covering health policy for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: President Biden came into office vowing to make coronavirus testing cheap and accessible, but matching supply with demand has been a persistent problem.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of ea

By the end of last year, if you needed a coronavirus test, you could get one. But when vaccines arrived, focus shifted.Many of the vaccinated felt like they didn’t need tests and demand took a nosedive. Testing sites were closed or converted into vaccination sites. And Abbott Laboratories, a major test manufacturer, wound up destroying millions.However, with the surge of the new Omicron variant, which is less susceptible to vaccines, demand for testing is back — and it is outstripping supply.Guest: Sheryl Gay Stolberg, a Washington correspondent, covering health policy for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: President Biden came into office vowing to make coronavirus testing cheap and accessible, but matching supply with demand has been a persistent problem.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of ea

Senator Joe Manchin of West Virginia was always going to be the last Democrat to get on board with President Biden’s $2.2 trillion climate, social spending and tax bill. But the White House was confident that a compromise could be reached.On Sunday, that confidence was shattered: In an interview on Fox News, Mr. Manchin essentially declared that he could not support the bill as written, and he indicated that he was done negotiating all together.Where does this leave Mr. Biden’s signature domestic policy goal?Guest: Emily Cochrane, a correspondent for The New York Times, based in Washington.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Mr. Manchin said on Sunday that he could not support the president’s signature bill, dooming his party’s drive to pass its marquee domestic policy legislation as written.Mr. Biden and his top aides have tried to salvage hopes of passing the

Senator Joe Manchin of West Virginia was always going to be the last Democrat to get on board with President Biden’s $2.2 trillion climate, social spending and tax bill. But the White House was confident that a compromise could be reached.On Sunday, that confidence was shattered: In an interview on Fox News, Mr. Manchin essentially declared that he could not support the bill as written, and he indicated that he was done negotiating all together.Where does this leave Mr. Biden’s signature domestic policy goal?Guest: Emily Cochrane, a correspondent for The New York Times, based in Washington.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Mr. Manchin said on Sunday that he could not support the president’s signature bill, dooming his party’s drive to pass its marquee domestic policy legislation as written.Mr. Biden and his top aides have tried to salvage hopes of passing the

This episode contains references to suicide and abuse that may be upsetting to some listeners.A few months ago, we told the story of N, a teenager in Afghanistan whose family was trying to force her to marry a member of the Taliban. Her identity has been concealed for her safety.N resisted, and her father and brother beat her, leading her to attempt suicide. Then she escaped.This is what happened after she fled her family’s home.Suicide Prevention Helplines: If you are having thoughts of suicide or are concerned that someone you know may be having those thoughts, in the United States call the National Suicide Prevention Lifeline at 800-273-8255 (TALK) or go to SpeakingOfSuicide.com/resources for a list of additional resources. Go here for resources outside the United States.Guest: Lynsea Garrison, a senior international producer for The Daily, spoke with N, a young woman whose life changed drastically after the fall of Kabul.Sign up here to get The Daily in your inbox each morning. And for an exclusive look a

This episode contains references to suicide and abuse that may be upsetting to some listeners.A few months ago, we told the story of N, a teenager in Afghanistan whose family was trying to force her to marry a member of the Taliban. Her identity has been concealed for her safety.N resisted, and her father and brother beat her, leading her to attempt suicide. Then she escaped.This is what happened after she fled her family’s home.Suicide Prevention Helplines: If you are having thoughts of suicide or are concerned that someone you know may be having those thoughts, in the United States call the National Suicide Prevention Lifeline at 800-273-8255 (TALK) or go to SpeakingOfSuicide.com/resources for a list of additional resources. Go here for resources outside the United States.Guest: Lynsea Garrison, a senior international producer for The Daily, spoke with N, a young woman whose life changed drastically after the fall of Kabul.Sign up here to get The Daily in your inbox each morning. And for an exclusive look a

Nearly a decade after the devastation of Hurricane Sandy, which destroyed piers and damaged riverside social housing projects, residents of Lower Manhattan are still vulnerable to floods.Michael Kimmelman, The Times’s architecture critic, explores the nine-year effort to redesign Lower Manhattan in the wake of the hurricane, and the design and planning challenges that have made progress incremental. He goes inside a fight over how to protect the neighborhood in the future — revealing why renewal in the face of climate disaster is so complicated.This story was narrated by Michael Kimmelman. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.The Headway initiative is funded through grants from the Ford Foundation, the William and Flora Hewlett Foundation and the Stavros Niarchos Foundation (SNF), with Rockefeller Philanthropy Advisors serving as a fiscal sponsor. The Woodcock Foundation is a funder of Headway’s public square.The New York Times works with ph

Nearly a decade after the devastation of Hurricane Sandy, which destroyed piers and damaged riverside social housing projects, residents of Lower Manhattan are still vulnerable to floods.Michael Kimmelman, The Times’s architecture critic, explores the nine-year effort to redesign Lower Manhattan in the wake of the hurricane, and the design and planning challenges that have made progress incremental. He goes inside a fight over how to protect the neighborhood in the future — revealing why renewal in the face of climate disaster is so complicated.This story was narrated by Michael Kimmelman. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.The Headway initiative is funded through grants from the Ford Foundation, the William and Flora Hewlett Foundation and the Stavros Niarchos Foundation (SNF), with Rockefeller Philanthropy Advisors serving as a fiscal sponsor. The Woodcock Foundation is a funder of Headway’s public square.The New York Times works with ph

The Omicron variant of the coronavirus is incredibly contagious — it is able to infect people with even greater frequency than the Delta variant, and it is skilled at evading the immune system’s defenses. Much is still unknown about the new variant, and scientists are racing to understand its threat. But amid the uncertainty, there’s good news about a prospective new virus treatment: A pill by Pfizer is effective in reducing people’s risk of hospitalization or death from Covid-19.We explore these two developments and what they could mean for the next phase of the pandemic.Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: An Omicron surge is likely. Here’s what to expect.Pfizer announced that its Covid pill was found to stave off severe disease in a key clinical trial and that it is

The Omicron variant of the coronavirus is incredibly contagious — it is able to infect people with even greater frequency than the Delta variant, and it is skilled at evading the immune system’s defenses. Much is still unknown about the new variant, and scientists are racing to understand its threat. But amid the uncertainty, there’s good news about a prospective new virus treatment: A pill by Pfizer is effective in reducing people’s risk of hospitalization or death from Covid-19.We explore these two developments and what they could mean for the next phase of the pandemic.Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: An Omicron surge is likely. Here’s what to expect.Pfizer announced that its Covid pill was found to stave off severe disease in a key clinical trial and that it is

Anti-abortion activists across the country are optimistic that they might be on the cusp of achieving a long-held goal of the movement: overturning Roe v. Wade, the 1973 Supreme Court decision that extended federal protections for abortion.But many abortion rights activists are hopeful, too. They are watching closely to see whether the Food and Drug Administration will roll back restrictions on one medication, transforming abortion access across the country. Today, we explore the future of America’s abortion fight.Guest: Pam Belluck, a health and science writer for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Who gets abortions in America? Here’s what we know.During the pandemic, health care providers can send abortion medication by mail. Will the courts allow that to continue?For more information on today’s episode, visit nytimes.com/thedaily. Transc

Anti-abortion activists across the country are optimistic that they might be on the cusp of achieving a long-held goal of the movement: overturning Roe v. Wade, the 1973 Supreme Court decision that extended federal protections for abortion.But many abortion rights activists are hopeful, too. They are watching closely to see whether the Food and Drug Administration will roll back restrictions on one medication, transforming abortion access across the country. Today, we explore the future of America’s abortion fight.Guest: Pam Belluck, a health and science writer for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Who gets abortions in America? Here’s what we know.During the pandemic, health care providers can send abortion medication by mail. Will the courts allow that to continue?For more information on today’s episode, visit nytimes.com/thedaily. Transc

The economic situation in Afghanistan is perilous. Banks have run out of cash. In some areas, Afghans are selling their belongings in ad hoc flea markets. Parents wait around hospitals and clinics in the hopes of getting treatment for severely malnourished children.We hear about what the unfolding crisis looks like on the ground, why the economy has deteriorated so quickly, and what role the United States has played.Guest: Christina Goldbaum, a correspondent for The New York Times, based in Kabul.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: An estimated 22.8 million people — more than half of Afghanistan’s population — are expected to face potentially life-threatening food insecurity this winter. Many are already on the brink of catastrophe.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next

The economic situation in Afghanistan is perilous. Banks have run out of cash. In some areas, Afghans are selling their belongings in ad hoc flea markets. Parents wait around hospitals and clinics in the hopes of getting treatment for severely malnourished children.We hear about what the unfolding crisis looks like on the ground, why the economy has deteriorated so quickly, and what role the United States has played.Guest: Christina Goldbaum, a correspondent for The New York Times, based in Kabul.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: An estimated 22.8 million people — more than half of Afghanistan’s population — are expected to face potentially life-threatening food insecurity this winter. Many are already on the brink of catastrophe.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next

In July, a group of men stormed the presidential compound in Haiti and assassinated the country’s president, Jovenel Moïse. Months later, the case remains unresolved.Investigating the killing, the Times journalist Maria Abi-Habib found that Mr. Moïse had begun compiling a list of powerful Haitian businessmen and political figures involved in an intricate drug trafficking network.Guest: Maria Abi-Habib, bureau chief for Mexico, Central America and the Caribbean for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Mr. Moïse took a number of steps to fight drug and arms smugglers. Some officials now fear he was killed for it.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Unlock full access to New York Times podcasts and explore everything from politics to pop cultu

In July, a group of men stormed the presidential compound in Haiti and assassinated the country’s president, Jovenel Moïse. Months later, the case remains unresolved.Investigating the killing, the Times journalist Maria Abi-Habib found that Mr. Moïse had begun compiling a list of powerful Haitian businessmen and political figures involved in an intricate drug trafficking network.Guest: Maria Abi-Habib, bureau chief for Mexico, Central America and the Caribbean for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Mr. Moïse took a number of steps to fight drug and arms smugglers. Some officials now fear he was killed for it.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Unlock full access to New York Times podcasts and explore everything from politics to pop cultu

This episode contains strong language. The Steele Dossier — compiled by Christopher Steele, a British former spy — was born out of opposition research on Donald J. Trump, then a presidential candidate, and his supposed links to Russia.The document, full of salacious allegations, captured and cleaved America. But now, a main source of the dossier’s findings — Igor Danchenko, a Russian analyst — has been charged with lying to federal investigators.Guest: Michael S. Schmidt, a Washington correspondent for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Mr. Trump and his backers say revelations about the Steele dossier show the Russia investigation was a “hoax.” That is not what the facts indicate.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Unlock full access to